InsiderClue
Insiders · Profile

Aftab Dana

EVP, Research and Development at EXELIXIS. Filing since 27 Feb 2023. CIK 0001959132

Company
Date
Role
Action
Shares
Amount
Of holding
EXEL EXELIXIS, INC.
26 May 2026
EVP, Research and Development
Sold at will
43,451
$2.19M
6.8%
EXEL EXELIXIS, INC.
24 Feb 2026
EVP, Research and Development
Sold at will
47,918
$2.13M
7.2%
EXEL EXELIXIS, INC.
19 Feb 2026
EVP, Research and Development
Sold at will
29,873
$1.32M
4.3%
EXEL EXELIXIS, INC.
11 Nov 2025
EVP, Research and Development
Sold at will
48,383
$2.06M
6.8%
EXEL EXELIXIS, INC.
1 May 2025
CSO/EVP Disc & Trans Research
Sold on a plan
1,508
$58.81K
0.2%
EXEL EXELIXIS, INC.
24 Feb 2025
CSO/EVP Disc & Trans Research
Sold at will
26,987
$991.77K
5.0%
EXEL EXELIXIS, INC.
5 Nov 2024
CSO/EVP Disc & Trans Research
Sold on a plan
96,986
$3.39M
16.3%
EXEL EXELIXIS, INC.
30 Oct 2024
CSO/EVP Disc & Trans Research
Sold on a plan
1,162
$36.49K
0.2%
EXEL EXELIXIS, INC.
12 Aug 2024
CSO/EVP Disc & Trans Research
Sold at will
20,883
$565.09K
4.0%
EXEL EXELIXIS, INC.
7 Aug 2024
CSO/EVP Disc & Trans Research
Sold on a plan
95,000
$2.38M
15.4%
EXEL EXELIXIS, INC.
30 Aug 2023
CSO/EVP Disc & Trans Research
Sold on a plan
4,600
$103.36K
1.1%
EXEL EXELIXIS, INC.
28 Feb 2023
CSO/EVP Disc & Trans Research
Sold, plan not stated
82,490
$1.44M
19.0%
EXEL EXELIXIS, INC.
27 Feb 2023
CSO/EVP Disc & Trans Research
Sold, plan not stated
10
$175.00
0.0%
13 decisions on file.